TVM Capital Steps up Its Involvement in Riemser Arzneimittel AG - GE Healthcare Financial Services Also Acquires an Interest in the Company

Munich-based investor TVM Capital and GE Healthcare Financial
Services now jointly hold 25.4% of shares in Riemser Arzneimittel AG,
with the remaining 74.6% owned by the Braun family. TVM Capital gained
a 10% share in the medium-sized pharmaceutical company located on
Riems Island in Mecklenburg-Vorpommern at the end of last year.

Together with the new shareholders, the firm´s management, led by
CEO Norbert Braun, will continue to pursue its international growth
and specialization strategy with determination. In the words of Dr
Christoph Schroder, TVM Capital partner and a member of Riemser´s
Supervisory Board, "We are looking forward to furthering
systematically the impressive development of Riemser AG. The growth
strategy pursued by the management can now be implemented even faster
and lead the company towards further market successes".

According to Theo Weber, Director of GE Healthcare Financial
Services Deutschland, "The main focus of our investment policy in the
healthcare and pharmaceuticals sector, combined with GE´s capacity to
cover the full range of financing services, make GE Healthcare
Financial Services the perfect partner for investing in Riemser
Arzneimittel AG, together with TVM Capital".

Additional editorial information:

TVM Capital

TVM Capital, founded in 1983 as Techno Venture Management, is one
of the first venture capital firms formed in Germany and was an early
entrant into the US market in 1986. Since its launch, TVM Capital has
raised more than EUR 1.3 billion in six fund generations and has
established itself as one of the leading VC companies in Europe. TVM
Capital funds have made investments in some 240 technology and life
science companies in Europe and the US - sectors where innovation,
effective management and sound financial backing have a major impact
on company growth. The firm´s in-depth knowledge of the European and
international market environment provides TVM Capital portfolio
companies with access to research, science and capital, and helps the
international development of management and distribution channels.
More than 50 TVM Capital-backed companies have gone public on European
or US stock exchanges. Today, TVM Capital is actively invested in over
70 companies. For more information, visit: www.tvm-capital.com

GE Healthcare Financial Services

GE Healthcare Financial Services is the leading provider of
financial solutions for the healthcare market. With over $17 billion
in assets, GE Healthcare Financial Services offers a full range of
financing capabilities from equipment leasing and real estate
financing to working capital lending and acquisition financing. With
its experience and in-depth knowledge of the healthcare industry, GE
Healthcare Financial Services offers its customers tailored financial
solutions. For more information, visit:
www.gehealthcarefinance.com/europe

RIEMSER Arzneimittel AG

RIEMSER Arzneimittel AG is a pharmaceutical company located in
Greifswald on Riems Island, in Mecklenburg-Vorpommen. RIEMSER AG
operates several companies in Germany, producing anti-inflammatory,
dermatological and dental drugs as well as medication to treat
tumorous and immunological diseases. The firm´s research and
development partners are renowned research institutes and universities
in Germany and Europe. Research partners in Mecklenburg-Vorpommern
include the Medical Faculty Institutes of the Universities of Rostock
and Greifswald as well as the renowned Riems Island Friedrich Loeffler
Institute (FLI). For more information, visit: www.riemser.de

The original source-language text of this announcement is the
official, authoritative version. Translations are provided as an
accommodation only, and should be cross-referenced with the
source-language text, which is the only version of the text intended
to have legal effect.